EPO and polycythemia: The polycythemia mouse model with JAK2 V617F mutation in hematopoietic cells gives rise to constitutively active EPOR, low EPO concentrations in the serum, low trabecular bone volume, and reduced osteoblast number (Oikonomidou et al., 2016).